Yokoyama, A. et al. Age-related remodelling of oesophageal epithelia by mutated cancer drivers. Nature 565, 312–317 (2019).
Google Scholar
Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911–917 (2018).
Google Scholar
King, C. et al. Somatic mutant selection is altered by prior NOTCH1 mutation in aging esophageal epithelium. Preprint at bioRxiv https://doi.org/10.1101/2024.09.26.615123 (2024).
Goka, E. T., Chaturvedi, P., Lopez, D. T. M., Garza, A. D. L. & Lippman, M. E. RAC1b overexpression confers resistance to chemotherapy treatment in colorectal cancer. Mol. Cancer Ther. 18, 957–968 (2019).
Google Scholar
Colom, B. et al. Spatial competition shapes the dynamic mutational landscape of normal esophageal epithelium. Nat. Genet. 52, 604–614 (2020).
Google Scholar
Colom, B. et al. Mutant clones in normal epithelium outcompete and eliminate emerging tumours. Nature 598, 510–514 (2021).
Google Scholar
Bolton, K. L. et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat. Genet. 52, 1219–1226 (2020).
Google Scholar
Kahn, J. D. et al. PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood 132, 1095–1105 (2018).
Google Scholar
Hsu, J. I. et al. PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell 23, 700–713 (2018).
Google Scholar
Coombs, C. C. et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell 21, 374–382 (2017).
Google Scholar
Smyth, E. C. et al. Oesophageal cancer. Nat. Rev. Dis. Primers 3, 17048 (2017).
Google Scholar
Nowicki-Osuch, K. et al. Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition. Science 373, 760–767 (2021).
Google Scholar
Al-Batran, S.-E. et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet 393, 1948–1957 (2019).
Google Scholar
Hoeppner, J. et al. Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer. N. Engl. J. Med. 392, 323–335 (2025).
Google Scholar
Obermannová, R. L. & Leong, T. ESMO Clinical Practice Guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma. ESMO Open 10, 104134 (2025).
Google Scholar
van Hagen, P. et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N. Engl. J. Med. 366 2074–2084 (2012).
Google Scholar
Abascal, F. et al. Somatic mutation landscapes at single-molecule resolution. Nature 593, 405–410(2021).
Google Scholar
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
Google Scholar
Chang, J. et al. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat. Commun. 8, 15290 (2017).
Google Scholar
Pich, O. et al. The mutational footprints of cancer therapies. Nat. Genet. 51, 1732–1740 (2019).
Google Scholar
Christensen, S. et al. 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer. Nat. Commun. 10, 4571 (2019).
Google Scholar
Ng, A. W. T. et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci. Transl. Med. 9, eaan6446 (2017).
Google Scholar
Kocakavuk, E. et al. Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer. Nat. Genet. 53, 1088–1096 (2021).
Google Scholar
Behjati, S. et al. Mutational signatures of ionizing radiation in second malignancies. Nat. Commun. 7, 12605 (2016).
Google Scholar
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041 (2017).
Google Scholar
Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880–886 (2015).
Google Scholar
Fowler, J. C. et al. Selection of oncogenic mutant clones in normal human skin varies with body site. Cancer Discov. 11, 340–361 (2021).
Google Scholar
Ye, J., Pavlicek, A., Lunney, E. A., Rejto, P. A. & Teng, C.-H. Statistical method on nonrandom clustering with application to somatic mutations in cancer. BMC Bioinformatics 11, 11 (2010).
Google Scholar
Kleiblova, P. et al. Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint. J. Cell Biol. 201, 511–521 (2013).
Google Scholar
Chen, Z. et al. Wip1 deficiency impairs haematopoietic stem cell function via p53 and mTORC1 pathways. Nat. Commun. 6, 6808 (2015).
Google Scholar
Zink, F. et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130, 742–752 (2017).
Google Scholar
Zhang, L., Hsu, J. I. & Goodell, M. A. PPM1D in solid and hematologic malignancies: friend and foe? Mol. Cancer Res. 20, 1365–1378 (2022).
Google Scholar
Herms, A. et al. Self-sustaining long-term 3D epithelioid cultures reveal drivers of clonal expansion in esophageal epithelium. Nat. Genet. 56, 2158–2173 (2024).
Google Scholar
Labun, K. et al. CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 47, W171–W174 (2019).
Google Scholar
Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR–Cas9. Nat. Biotechnol. 34, 184–191 (2016).
Google Scholar
Abby, E. et al. Notch1 mutations drive clonal expansion in normal esophageal epithelium but impair tumor growth. Nat. Genet. 55, 232–245 (2023).
Google Scholar
Murai, K. et al. p53 mutation in normal esophagus promotes multiple stages of carcinogenesis but is constrained by clonal competition. Nat. Commun. 13, 6206 (2022).
Google Scholar
Kim, J. et al. Integrated genomic characterization of oesophageal carcinoma. Nature 541, 169–175 (2017).
Google Scholar
Chang, J. et al. Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development. Cancer Cell 41, 2038–2050 (2023).
Google Scholar
Cuneo, M. J., O’Flynn, B. G., Lo, Y.-H., Sabri, N. & Mittag, T. Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation. Mol. Cell 83, 731–745 (2023).
Google Scholar
Zhang, H., Jin, X. & Huang, H. Deregulation of SPOP in cancer. Cancer Res. 83, 489–499 (2023).
Google Scholar
Shi, Q. et al. Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly. Mol. Cancer 18, 170 (2019).
Google Scholar
Blattner, M. et al. SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K/mTOR and AR signaling. Cancer Cell 31, 436–451(2017).
Google Scholar
Ostertag, M. S., Hutwelker, W., Plettenburg, O., Sattler, M. & Popowicz, G. M. Structural insights into BET client recognition of endometrial and prostate cancer-associated SPOP mutants. J. Mol. Biol. 431, 2213–2221 (2019).
Google Scholar
Janouskova, H. et al. Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors. Nat. Med. 23, 1046–1054 (2017).
Google Scholar
Cavalcante, L. et al. Opposing roles of SPOP mutations in human prostate and endometrial cancers. JCO Precis. Oncol. 7, e2300088 (2023).
Abeshouse, A. et al. The molecular taxonomy of primary prostate cancer. Cell 163, 1011–1025 (2015).
Google Scholar
Theurillat, J.-P. P. et al. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer. Science346, 85–89 (2014).
Google Scholar
Gan, W. et al. SPOP promotes ubiquitination and degradation of the erg oncoprotein to suppress prostate cancer progression. Mol. Cell 59, 917–930 (2015).
Google Scholar
Zhang, D. D. Thirty years of NRF2: advances and therapeutic challenges. Nat. Rev. Drug Discov. 24, 421–444 (2025).
Google Scholar
Bailly, C., Beignet, J., Loirand, G. & Sauzeau, V. Rac1 as a therapeutic anticancer target: promises and limitations. Biochem. Pharmacol. 203, 115180 (2022).
Google Scholar
Panwar, V. et al. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct. Target. Ther. 8, 375 (2023).
Google Scholar
Pillai, R., Hayashi, M., Zavitsanou, A.-M. & Papagiannakopoulos, T. NRF2: KEAPing tumors protected. Cancer Discov. 12, 625–643 (2022).
Google Scholar
Shibata, T. et al. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer. Neoplasia 13, 864–873 (2011).
Google Scholar
Akhdar, H. et al. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells. Eur. J. Cancer 45, 2219–2227 (2009).
Google Scholar
Kim, E. J. et al. NRF2 knockdown resensitizes 5-fluorouracil-resistant pancreatic cancer cells by suppressing HO-1 and ABCG2 expression. Int. J. Mol. Sci. 21, 4646 (2020).
Google Scholar
Benitah, S. A., Frye, M., Glogauer, M. & Watt, F. M. Stem cell depletion through epidermal deletion of Rac1. Science309, 933–935 (2005).
Google Scholar
Tscharntke, M. et al. Impaired epidermal wound healing in vivo upon inhibition or deletion of Rac1. J. Cell Sci. 120, 1480–1490 (2007).
Google Scholar
Senyuz, S., Jang, H., Nussinov, R., Keskin, O. & Gursoy, A. Mechanistic differences of activation of Rac1P29S and Rac1A159V. J. Phys. Chem. B 125, 3790–3802 (2021).
Google Scholar
Davis, M. J. et al. RAC1P29S is a spontaneously activating cancer-associated GTPase. Proc. Natl Acad. Sci. USA 110, 912–917 (2013).
Google Scholar
Acuner, S. E., Sumbul, F., Torun, H. & Haliloglu, T. Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 binding. Biophys. J. 120, 866–876 (2021).
Google Scholar
Grabiner, B. C. et al. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. Cancer Discov. 4, 554–563 (2014).
Google Scholar
Xu, J. et al. Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin. J. Clin. Invest. 126, 3526–3540 (2016).
Google Scholar
Kim, D. et al. Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease. Nat. Commun. 11, 2246 (2020).
Lorenz, M. C. & Heitman, J. TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J. Biol. Chem. 270, 27531–27537 (1995).
Google Scholar
Pich, O. et al. Somatic evolution following cancer treatment in normal tissue. Nature 653, 900–910 (2026).
Google Scholar
Wenger, A. Extensive and differential platinum chemotherapy mutagenesis in children. Preprint at bioRxiv https://doi.org/10.1101/2025.10.12.681852 (2025).
Mitchell, E. et al. The long-term effects of chemotherapy on normal blood cells. Nat. Genet. 57, 1684–1694 (2025).
Google Scholar
Sánchez-Guixé, M. et al. Origins of second malignancies in children and mutational footprint of chemotherapy in normal tissues. Cancer Discov. 14, 953–964 (2024).
Google Scholar
Boot, A. et al. In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors. Genome Res. 28, 654–665 (2018).
Google Scholar
Fernandez-Antoran, D. et al. Outcompeting p53-mutant cells in the normal esophagus by redox manipulation. Cell Stem Cell 25, 329–341 (2019).
Google Scholar
Grantzau, T. & Overgaard, J. Risk of second non-breast cancer after radiotherapy for breast cancer: a systematic review and meta-analysis of 762,468 patients. Radiother. Oncol. 114, 56–65 (2015).
Google Scholar
Zablotska, L. B., Chak, A., Das, A. & Neugut, A. I. Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer. Am. J. Epidemiol. 161, 330–337 (2005).
Google Scholar
Simone, C. B. 2nd Thoracic radiation normal tissue injury. Semin. Radiat. Oncol. 27, 370–377 (2017).
Google Scholar
Holt, F. et al. Estimated doses to the heart, lungs and oesophagus and risks from typical UK radiotherapy for early breast cancer during 2015–2023. Clin. Oncol. 36, e322–e332 (2024).
Google Scholar
Peters, G. J. et al. Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim. Biophys. Acta 1587, 194–205 (2002).
Google Scholar
Schmitt, M. et al. Colon tumour cell death causes mTOR dependence by paracrine P2X4 stimulation. Nature 612, 347–353 (2022).
Google Scholar
Jiang, X. et al. High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients. Mod. Pathol. 35, 929–937 (2022).
Google Scholar
Fowler, J. C. & Jones, P. H. Somatic mutation: what shapes the mutational landscape of normal epithelia? Cancer Discov. 12, 1642–1655 (2022).
Google Scholar
Shorthouse, D. shorthouse-lab/fowler_selection: Publication Release. Zenodo https://doi.org/10.5281/zenodo.21505780 (2026).
Obermannová, R. et al. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 992–1004 (2022).
Google Scholar
Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. Nature 574, 532–537 (2019).
Google Scholar
Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at ArXiv https://doi.org/10.48550/arXiv.1303.3997 (2013).
Danecek, P. et al. Twelve years of SAMtools and BCFtools. Gigascience 10, giab008 (2021).
Google Scholar
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Google Scholar
Jones, D. et al. cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data. Curr. Protoc. Bioinformatics 56, 15.10.1–15.10.18 (2016).
Google Scholar
Raine, K. M. et al. cgpPindel: identifying somatically acquired insertion and deletion events from paired end sequencing. Curr. Protoc. Bioinformatics 52, 15.7.1–15.7.12 (2015).
Google Scholar
Menzies, A. et al. VAGrENT: variation annotation generator. Curr. Protoc. Bioinformatics 52, 15.8.1–15.8.11 (2015).
Google Scholar
Raine, K. M. et al. ascatNgs: identifying somatically acquired copy-number alterations from whole-genome sequencing data. Curr. Protoc. Bioinformatics 56, 15.9.1–15.9.17 (2016).
Google Scholar
Rahman, S., Kosakovsky Pond, S. L., Webb, A. & Hey, J. Weak selection on synonymous codons substantially inflates dN/dS estimates in bacteria. Proc. Natl Acad. Sci. USA 118, e2023575118 (2021).
Google Scholar
Albu, M., Min, X. J., Hickey, D. & Golding, B. Uncorrected nucleotide bias in mtDNA can mimic the effects of positive Darwinian selection. Mol. Biol. Evol. 25, 2521–2524 (2008).
Google Scholar
Hanley, J. A. & Lippman-Hand, A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 249, 1743–1745 (1983).
Google Scholar
Hall, M. W. J., Shorthouse, D., Alcraft, R., Jones, P. H. & Hall, B. A. Mutations observed in somatic evolution reveal underlying gene mechanisms. Commun. Biol. 6, 753 (2023).
Google Scholar
Burley, S. K. et al. Protein Data Bank: the single global archive for 3D macromolecular structure data. Nucleic Acids Res. 47, D520–D528 (2019).
Google Scholar
Delgado, J., Radusky, L. G., Cianferoni, D. & Serrano, L. FoldX 5.0: working with RNA, small molecules and a new graphical interface. Bioinformatics 35, 4168–4169 (2019).
Google Scholar
Jamshidi Parvar, S., Hall, B. A. & Shorthouse, D. Interpreting the effect of mutations to protein binding sites from large-scale genomic screens. Methods 222, 122–132 (2024).
Google Scholar
Radusky, L. G. & Serrano, L. pyFoldX: enabling biomolecular analysis and engineering along structural ensembles. Bioinformatics 38, 2353–2355 (2022).
Google Scholar
Bakan, A., Meireles, L. M. & Bahar, I. ProDy: protein dynamics inferred from theory and experiments. Bioinformatics 27, 1575–1577 (2011).
Google Scholar
Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015).
Google Scholar
Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950–1958 (2010).
Google Scholar
Michaud-Agrawal, N., Denning, E. J., Woolf, T. B. & Beckstein, O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J. Comput. Chem. 32, 2319–2327 (2011).
Google Scholar
Naughton, F. B. et al. MDAnalysis 2.0 and beyond: fast and interoperable, community driven simulation analysis. Biophys. J. 121, 272A–273A (2022).
Google Scholar
Brunon, S. & Abnizova, I. Fowler_et_al. (v.1.1.0). Zenodo https://doi.org/10.5281/zenodo.21495557 (2026).
